UMSOM wins $3.5 million BARDA contract to develop animals models for radiation research

University of Maryland School of Medicine Dean Mark T. Gladwin, MD, announced today that UMSOM faculty scientists have been selected as key contractors by the Biomedical Advanced Research and Development Authority (BARDA), for the federal agency’s Radiation Nuclear Animal Model Development program.

Cannabis Sectors Have Mixed June Performance

As we described in a previous article, the Global Cannabis Stock Index moved lower in June, falling 8.9%. It is now up 6.2% in 2024. In this article,

June 29, 2024

Braxia Scientific Reports Q2 2024 Financial Results and Provides Corporate Update | Psychedelic Invest

Braxia Scientific Corp. (CSE: BRAX) (OTC Pink: BRAXF) (FSE: 4960) (“Braxia Scientific”, or the “Company”), a medical research company with clinics providing innovative ketamine and psilocybin treatments

November 30, 2023

Bristol Myers Squibb’s Abecma recommended for EU approval

Share this article EMA CHMP endorses Bristol Myers Squibb’s Abecma for the treatment of adult multiple myeloma patients in the EU. Credit: Amy Lutz /

January 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.